Medical News

RSS

Positive top-line results from IPX066 Phase III study in patients with PD

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., today announced statistically significant, positive, top-line results of the ADVANCE-Parkinson's Disease Phase III clinical study of the safety and efficacy of IPX066 versus immediate-release carbidopa-levodopa in advanced PD patients experiencing motor fluctuations.

15 Mar 2011

Bayer receives FDA approval for Gadavist Injection

Bayer HealthCare Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration has approved Gadavist Injection, a macrocyclic gadolinium-based contrast agent, for intravenous use in diagnostic magnetic resonance imaging in adults and children to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity of the central nervous system.

14 Mar 2011

Depressed Dads more likely to spank their infants: Study

Until now it has been seen that post partum depression affects women in nearly 25% of cases. However latest research shows that new dads experience baby blues too. The results show that 7% of new fathers reported recent major depression, and many of them said they had spanked their 1-year-old babies. This new study appeared Monday in the journal Pediatrics.

14 Mar 2011

Dog owners more physically active: proven many times over now

There is enough scientific evidence now to show that dogs can be powerful motivators to get people moving. Dog owners are more likely to take regular walks and new research has shown that dog walkers are more active overall than people who don’t have dogs. One of the studies showed that older people are more likely to take regular walks if the walking companion is canine rather than human.

14 Mar 2011

Bad jobs can make one mentally ill: Study

A latest study shows that a job that provides low control, high demands, complexity and the perception of unfair pay may lead to worse mental health than being unemployed. The study appeared in the journal Occupational Environmental Medicine.

14 Mar 2011

Radiation exposure explained

Amidst threat of major nuclear accident in Japan, people are in a state of panic worldwide said Jerrold Bushberg, a medical physicist at UC Davis. Bushberg said Americans do not have a good knowledge of the science of radiation and tend to over-exaggerate the risks.

14 Mar 2011

Baby Joseph’s flight to US from Canada

Baby Joseph Maraachli all of one year of age, is in a vegetative state with a severe neurological condition and will not recover, Canadian doctors say. His parents Moe Maraachli and Sana Nader, have transferred him to a US Catholic hospital after an Ontario court ruled doctors could remove a breathing tube keeping him alive. An Ontario hospital had refused his parents' request for a tracheotomy they say will prolong his life by six months and allow him to die at home. A Catholic hospital in the US city of St Louis will review his case, according to the family’s lawyer.

14 Mar 2011

Taking health technology to the top

At the Innovations in Health and Community Care Forum at Old Parliament House on Thursday 3 March, leading health academics and professionals presented compelling arguments supporting the need for integrating assistive technology into health and community models of care.

14 Mar 2011

Repligen reports positive results from RG1068 Phase 3 study to improve MRI of the pancreas

Repligen Corporation reported today positive top-line results from a Phase 3 study to evaluate the safety and efficacy of RG1068, synthetic human secretin, to improve magnetic resonance imaging (MRI) of the pancreas in patients with pancreatic disease using endoscopy (ERCP) as a diagnostic reference.

14 Mar 2011

Nanoscale whiskers could hold key to creating working human muscle tissue

Minute whiskers of nanoscale dimensions taken from sea creatures could hold the key to creating working human muscle tissue, University of Manchester researchers have discovered.

14 Mar 2011

Hanger Orthopedic Group amends existing Credit Agreement

Hanger Orthopedic Group, Inc. announced today that it has amended its existing Credit Agreement to lower the applicable interest rates and modify certain other covenants. The Amendment (i) reduces the interest rate margin applicable to the term loan under the Credit Agreement by 0.75% to 3.00% and (ii) reduces the LIBOR floor applicable to the term loan under the Credit Agreement from 1.50% to 1.00%.

14 Mar 2011

EHNAC accredits Sourcenet as first medical biller

The Electronic Healthcare Network Accreditation Commission (EHNAC), a non-profit standards development organization and accrediting body, announced today that it has accredited its first medical biller under the Healthcare Network Accreditation Program (HNAP) Medical Biller. Sourcenet, a premier physician billing and practice management firm, achieved full accreditation and is recognized as adhering to strict health data processing and transactions, and ensuring compliance with industry-established standards and HIPAA regulations.

14 Mar 2011

Medica Foundation awards $1 million in grants to five Minnesota organizations

The Medica Foundation today announced $1 million in grants to five Minnesota organizations. The grant amounts range from $100,000 to $300,000 each and are designed to provide funding to the recipients over a three-year period.

14 Mar 2011

BioMed declares $0.20 first quarter dividend

BioMed Realty Trust, Inc. today announced that its board of directors has declared a first quarter 2011 dividend of $0.20 per share of common stock, representing a 17.6% increase over the company's fourth quarter 2010 dividend of $0.17 per share. The dividend is equivalent to an annualized dividend of $0.80 per common share.

14 Mar 2011

GOP emphasizing need for states to lead on health reform

A leading Senate Republican said Friday that the welfare reforms put in place during the 1990s, which gave states considerable flexibility, should be used as the model for the shape of a health law replacement plan.

14 Mar 2011

OrbusNeich launches CE marked Azule Cobalt Chromium Stent

OrbusNeich today announced the launch of the CE marked Azule Cobalt Chromium Stent. The Azule Stent combines the proven stent design of its predecessor, the company's Blazer™ Cobalt Chromium Stent, with a delivery system with enhanced crossability and flexible deliverability.

14 Mar 2011

Milestone Scientific commences trading on OTCQB

Milestone Scientific Inc. which develops, manufactures, and markets computer-controlled injection systems for medical and dental markets, today announced that its common stock has commenced trading on the OTCQB(TM) electronic quotation and trading system under the ticker symbol MLSS.PK. Stockholders are not required to take any action as a result of the addition of the Company's securities to the OTCQB(TM).

14 Mar 2011

Air Techniques' Spectra device leads caries detection aid category in sales

Air Techniques, Inc., a leading dental equipment manufacturer, announced today that its Spectra device led the caries detection aid category in dollar sales with a 2010 market share of almost 50%. In addition, in the fourth quarter of 2010, Spectra for the first time also led the category in units sold, and it set a record with a dollar market share of over 60%.

14 Mar 2011

Gamida to distribute Health Robotics' CytoCare, i.v.STATION, i.v.SOFT technologies in Israel

Health Robotics today announced that it recently signed an exclusive distribution agreement for its CytoCare, i.v.STATION, and i.v.SOFT world-leading technologies with Israel-based medical technology leader Gamida MedEquip Ltd.

14 Mar 2011

Euthymics Bioscience initiates EB-1010 phase 2b/3a TRIADE clinical trial for major depressive disorder

Euthymics Bioscience, Inc. today announced the initiation of an advanced clinical study of its lead product candidate EB-1010 for the treatment of major depressive disorder (MDD). The TRIADE (Triple Reuptake Inhibitor Anti-Depressant Effects) trial is a phase 2b/3a clinical trial designed to assess the safety and efficacy of EB-1010, a novel serotonin-preferring triple reuptake inhibitor.

14 Mar 2011